# Palmitoyl Tripeptide-5 (Peptide)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/palmitoyl-tripeptide-5
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Pal-Lys-Val-Lys-OH, Palmitoyl Tripeptide-5, TSP-1 mimetic peptide, Thrombospondin-1 fragment peptide, Palmitoylated tripeptide, Syn-Coll peptide, Collagen synthesis peptide

## Overview

Palmitoyl Tripeptide-5 is a synthetic lipopeptide composed of a palmitoyl fatty acid chain linked to the tripeptide sequence Lys-Val-Lys, designed to mimic the collagen-stimulating domain of thrombospondin-1. It activates TGF-β (transforming growth factor-beta) signaling pathways to upregulate collagen types I, II, and IV synthesis in dermal fibroblasts.

## Health Benefits

• Stimulates [collagen synthesis](/ingredients/condition/skin-health) (types I, II, IV) through TGF-β activation (in-vitro evidence only)
• Promotes fibronectin production and extracellular matrix repair (in-vitro evidence only)
• May reduce matrix metalloproteases (MMPs) expression (theoretical mechanism, no clinical evidence)
• Potentially reduces [pro-inflammatory cytokine](/ingredients/condition/inflammation)s and vasodilation (theoretical mechanism, no clinical evidence)
• Previously used in cosmetic mix for type I rosacea redness reduction (anecdotal evidence, study details unavailable)

## Mechanism of Action

Palmitoyl Tripeptide-5 mimics the sequence of thrombospondin-1, a natural activator of latent TGF-β, binding to and activating TGF-β receptors on dermal fibroblasts to upregulate transcription of collagen types I, II, and IV. This cascade also promotes fibronectin secretion and extracellular matrix (ECM) remodeling by downregulating matrix metalloproteinases (MMPs), particularly MMP-1 and MMP-3, which are enzymes responsible for collagen degradation. The palmitoyl lipid chain facilitates percutaneous absorption by increasing the peptide's affinity for the stratum corneum lipid bilayer.

## Clinical Summary

The majority of evidence supporting Palmitoyl Tripeptide-5 derives from in-vitro fibroblast cell culture studies demonstrating increased collagen and fibronectin gene expression, with limited translation to robust human clinical trials. One manufacturer-sponsored split-face study reported measurable reductions in wrinkle depth after 12 weeks of twice-daily topical application at concentrations around 4 ppm, though full methodology and sample sizes were not independently peer-reviewed. No large-scale, placebo-controlled randomized clinical trials (RCTs) with statistically significant, independently replicated outcomes have been published in indexed journals as of 2024. Evidence strength is currently rated low-to-moderate, and claims of efficacy should be interpreted cautiously pending independent clinical validation.

## Nutritional Profile

{"macronutrients": {"protein": "Not applicable", "carbohydrates": "Not applicable", "fats": "Not applicable", "fiber": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"Palmitoyl Tripeptide-5": "Concentration not typically quantified in nutritional terms; used in cosmetic formulations for skin benefits.", "Bioavailability": "Topical application; bioavailability depends on formulation and skin penetration enhancers."}}

## Dosage & Preparation

No clinically studied dosage ranges have been established for Palmitoyl Tripeptide-5 as no human trials are documented. Commercial formulations contain approximately 900-1300 ppm (about 1g peptide per 1kg solution). Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Palmitoyl Tripeptide-5 has a well-established topical safety profile and is generally considered non-irritating, non-sensitizing, and non-comedogenic at concentrations used in cosmetic formulations (typically 0.001%–0.01% by weight). No significant systemic absorption has been documented at standard topical doses, and no known drug interactions have been reported for dermal application. It is not classified as a drug by the FDA, so no formal contraindications exist; however, individuals with known hypersensitivity to palmitoyl peptides should perform patch testing prior to use. Data on safety during pregnancy and lactation are insufficient, and caution is advised as a precautionary measure.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Palmitoyl Tripeptide-5 according to available sources. Only in-vitro studies demonstrate its ability to activate TGF-β and stimulate [collagen synthesis](/ingredients/condition/skin-health). No PubMed PMIDs are available for human studies.

## Historical & Cultural Context

Palmitoyl Tripeptide-5 has no historical or traditional use in any medicine systems. It is a modern synthetic peptide developed for cosmetic applications with no pre-commercial or cultural context.

## Synergistic Combinations

Vitamin C, Retinol, Hyaluronic Acid, Copper Peptides, Matrixyl

## Frequently Asked Questions

### How does palmitoyl tripeptide-5 differ from palmitoyl pentapeptide-4 (Matrixyl)?

Palmitoyl Tripeptide-5 mimics thrombospondin-1 to indirectly activate TGF-β signaling for collagen stimulation, while Palmitoyl Pentapeptide-4 (Matrixyl) mimics a procollagen sequence to directly signal fibroblasts via fibronectin receptors. Both upregulate collagen synthesis, but through distinct molecular entry points, making them potentially complementary in anti-aging formulations rather than redundant ingredients.

### What concentration of palmitoyl tripeptide-5 is effective in skincare products?

Palmitoyl Tripeptide-5 is typically used in cosmetic formulations at concentrations between 0.001% and 0.01% (approximately 1–4 ppm) by weight, as the palmitoyl chain enhances skin penetration efficiency at low doses. Manufacturer-sponsored data suggest activity begins at roughly 4 ppm for collagen gene upregulation in fibroblasts, though no independent dose-response clinical studies have established an optimal threshold for visible anti-aging outcomes in humans.

### Can palmitoyl tripeptide-5 actually increase collagen production in human skin?

In-vitro studies on cultured human dermal fibroblasts confirm that Palmitoyl Tripeptide-5 upregulates mRNA expression of collagen types I, II, and IV via TGF-β receptor activation. However, peer-reviewed, independent clinical trials measuring actual dermal collagen density in living human subjects via biopsy or validated imaging are lacking as of 2024, meaning definitive proof of significant in-vivo collagen synthesis remains unestablished.

### Is palmitoyl tripeptide-5 safe to use around the eyes?

Palmitoyl Tripeptide-5 is widely formulated in periorbital (eye cream) products and has not been associated with eye irritation, mucosal sensitivity, or systemic toxicity in cosmetic use at standard concentrations below 0.01%. The Cosmetic Ingredient Review (CIR) Expert Panel has not flagged palmitoyl peptides as unsafe for periocular use, though individuals with sensitive skin or a history of contact dermatitis should conduct a patch test before regular application near the eye contour.

### How long does it take to see results from palmitoyl tripeptide-5 in skincare?

Based on the available manufacturer-sponsored split-face study data, measurable changes in wrinkle depth and skin texture were reported after 8–12 weeks of consistent twice-daily topical application at concentrations around 4 ppm. Because collagen synthesis and ECM remodeling are slow biological processes driven by fibroblast activity, shorter durations of use are unlikely to produce visible changes, and results will vary based on formulation vehicle, skin type, and baseline collagen status.

### What is the difference between in-vitro evidence and clinical evidence for palmitoyl tripeptide-5?

In-vitro evidence means the ingredient was tested in laboratory conditions (petri dishes or test tubes) rather than on human skin in real-world conditions. Most collagen-stimulating claims for palmitoyl tripeptide-5 are based on in-vitro studies, which show promise but do not guarantee the same results will occur when applied topically to living human skin. Clinical evidence from human trials is considered more reliable for skincare efficacy claims.

### Is palmitoyl tripeptide-5 suitable for all skin types?

Palmitoyl tripeptide-5 is generally considered suitable for all skin types, including sensitive skin, since it is a small peptide designed to support the skin barrier rather than exfoliate or irritate. However, individual tolerability may vary depending on the formulation's other ingredients and a person's specific sensitivities. A patch test is recommended before incorporating it into a regular skincare routine.

### How does palmitoyl tripeptide-5 work differently than topical retinoids or vitamin C for anti-aging?

Palmitoyl tripeptide-5 theoretically stimulates collagen production through TGF-β signaling pathways, whereas retinoids work by increasing cell turnover and vitamin C acts as an antioxidant and collagen crosslinker. Unlike retinoids, palmitoyl tripeptide-5 does not cause photosensitivity or require gradual introduction, making it potentially more suitable for sensitive skin, though clinical evidence supporting its efficacy remains limited compared to retinoids.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*